What is the ticker symbol for Xeris Biopharma?

Xeris Biopharma trades under the ticker XERS on NASDAQ.

What sector does Xeris Biopharma operate in?

Xeris Biopharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze XERS in a portfolio?

PortView shows XERS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Xeris Biopharma (XERS) Stock Analysis

NASDAQHealthcareBiotechnology

$8.39-0.53%

1-year price historyRange $5.29 – $9.90

52-week range$8.39

$5.25$10.08

What Xeris Biopharma does

Xeris Biopharma Holdings, Inc. operates as a biopharmaceutical company, focusing on the development and commercialization of therapeutic solutions for individuals across the fields of endocrinology, neurology, and gastroenterology. Its current portfolio includes: Gvoke: A ready-to-administer liquid glucagon designed to treat severe hypoglycemia. Keveyis: A therapy addressing hyperkalemic, hypokalemic, and related forms of primary periodic paralysis. Recorlev: A cortisol synthesis inhibitor approved for managing endogenous hypercortisolemia in adult patients with Cushing's syndrome. Beyond its marketed products, the company maintains an active development pipeline. This pipeline seeks to broaden the applications and indications for existing treatments and introduce novel pharmaceuticals leveraging its proprietary XeriSol and XeriJect formulation technology platforms. Founded in 2005, Xeris Biopharma is headquartered in Chicago, Illinois.

Key metrics

Market cap

$1.45B

P/E (TTM)

-78.73

EPS (TTM)

$-0.11

Beta

0.85

Dividend yield

0.00%

Revenue / share

$1.94

50-day avg

$8.32

200-day avg

$7.02

52-week high

$10.08

52-week low

$5.25

CEO

John Shannon

ETFs linked to XERS

Broad-market and Healthcare sector ETFs an investor holding Xeris Biopharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how XERS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze XERS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Xeris Biopharma?: Xeris Biopharma trades under the ticker XERS on NASDAQ.
Which exchange is XERS listed on?: XERS is listed on NASDAQ.
What sector does Xeris Biopharma operate in?: Xeris Biopharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze XERS in a portfolio?: PortView shows XERS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.